Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (578)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
159
2024
2915
11.420
Why?
Antibodies, Monoclonal
26
2024
457
6.320
Why?
Hematopoietic Stem Cell Transplantation
28
2024
555
3.440
Why?
Antineoplastic Agents
18
2024
1175
3.340
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
994
3.320
Why?
Humans
210
2024
49877
2.230
Why?
Thalidomide
24
2024
374
2.020
Why?
Monoclonal Gammopathy of Undetermined Significance
10
2024
111
1.910
Why?
Neoplasm Recurrence, Local
15
2024
626
1.820
Why?
Immunotherapy, Adoptive
9
2024
158
1.800
Why?
Killer Cells, Natural
8
2024
107
1.760
Why?
Transplantation, Autologous
26
2024
462
1.750
Why?
Interleukin-6
12
2023
265
1.670
Why?
Neoplasm Proteins
13
2022
321
1.600
Why?
Hematologic Neoplasms
3
2022
98
1.590
Why?
Middle Aged
72
2024
12289
1.470
Why?
Antigens, Neoplasm
6
2014
146
1.450
Why?
Clinical Trials as Topic
13
2022
466
1.430
Why?
Stem Cell Transplantation
10
2022
179
1.360
Why?
Prognosis
45
2024
1957
1.320
Why?
Gene Expression Regulation, Neoplastic
20
2022
824
1.280
Why?
Aged
72
2024
9450
1.270
Why?
Combined Modality Therapy
19
2024
638
1.250
Why?
Chromosomes, Human, Pair 1
9
2023
92
1.250
Why?
Herpesvirus 8, Human
7
2021
95
1.210
Why?
Translocation, Genetic
10
2022
263
1.180
Why?
Treatment Outcome
47
2024
5174
1.140
Why?
B-Cell Maturation Antigen
8
2024
88
1.130
Why?
Boronic Acids
12
2013
182
1.110
Why?
Pyrazines
12
2013
187
1.110
Why?
Male
82
2024
25427
1.100
Why?
Adult
52
2024
13344
1.100
Why?
Female
84
2024
26555
1.090
Why?
Bone Marrow
18
2024
351
1.060
Why?
Proteasome Inhibitors
5
2024
104
1.050
Why?
Antibodies, Bispecific
5
2024
70
1.010
Why?
Immunotherapy
6
2024
235
1.000
Why?
Gene Expression Profiling
26
2023
1028
0.990
Why?
Neoplasms, Second Primary
2
2024
74
0.980
Why?
Disease-Free Survival
24
2019
450
0.940
Why?
B-Lymphocytes
5
2024
175
0.920
Why?
Dexamethasone
14
2024
424
0.910
Why?
T-Lymphocytes, Cytotoxic
4
2014
65
0.890
Why?
Melphalan
9
2020
173
0.880
Why?
Cancer Vaccines
3
2010
78
0.870
Why?
Follow-Up Studies
26
2024
2176
0.860
Why?
Plasma Cells
11
2023
221
0.840
Why?
Hyperhidrosis
1
2022
2
0.830
Why?
Sweat
1
2022
7
0.830
Why?
Survival Rate
24
2020
905
0.810
Why?
Lymphoma, B-Cell
3
2022
61
0.790
Why?
Drug Approval
1
2022
47
0.790
Why?
Ehrlichia chaffeensis
1
2021
4
0.760
Why?
Patient Participation
1
2022
67
0.750
Why?
T-Lymphocytes
8
2024
328
0.750
Why?
Ehrlichiosis
1
2021
14
0.750
Why?
Cryosurgery
1
2021
35
0.740
Why?
Immunoglobulin Light Chains
3
2017
82
0.730
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
27
0.720
Why?
Embolization, Therapeutic
1
2021
85
0.700
Why?
Cell Proliferation
10
2023
986
0.690
Why?
Disease Progression
16
2023
820
0.680
Why?
Chromosomal Instability
1
2019
16
0.670
Why?
Membrane Proteins
3
2006
347
0.650
Why?
Neoplasms, Plasma Cell
3
2024
35
0.650
Why?
Survival Analysis
18
2024
670
0.640
Why?
Adrenal Cortex Hormones
2
2023
98
0.640
Why?
Immunologic Factors
2
2018
112
0.630
Why?
Epigenesis, Genetic
4
2023
370
0.620
Why?
Neoplasm, Residual
8
2022
156
0.610
Why?
Tumor Microenvironment
6
2024
221
0.610
Why?
Chromosome Aberrations
12
2023
295
0.600
Why?
Atrial Fibrillation
2
2022
182
0.600
Why?
POEMS Syndrome
1
2018
31
0.600
Why?
Dendritic Cells
3
2014
133
0.600
Why?
Thyroid Neoplasms
1
2019
112
0.580
Why?
Polymorphism, Single Nucleotide
3
2024
483
0.570
Why?
Prealbumin
2
2014
20
0.570
Why?
Antibodies, Monoclonal, Humanized
6
2023
223
0.560
Why?
Positron-Emission Tomography
7
2022
286
0.550
Why?
Receptors, Interleukin-6
2
2014
22
0.540
Why?
Cardiomyopathies
2
2014
114
0.520
Why?
Mutation
10
2022
1291
0.500
Why?
Aged, 80 and over
19
2024
3137
0.500
Why?
Osteolysis
4
2022
75
0.480
Why?
Immunotoxins
1
2014
6
0.470
Why?
Drug Resistance, Neoplasm
7
2024
314
0.460
Why?
Recurrence
13
2024
658
0.460
Why?
Cytotoxicity, Immunologic
2
2012
56
0.460
Why?
Clonal Evolution
3
2020
56
0.450
Why?
Practice Guidelines as Topic
4
2023
456
0.450
Why?
Risk Factors
19
2024
3608
0.430
Why?
Cyclophosphamide
5
2021
163
0.430
Why?
Amyloidosis
1
2014
77
0.430
Why?
Transplantation, Homologous
5
2017
140
0.430
Why?
Health Status
1
2015
299
0.420
Why?
Fluorodeoxyglucose F18
6
2021
189
0.410
Why?
Genome-Wide Association Study
3
2024
163
0.400
Why?
Remission Induction
13
2021
205
0.400
Why?
Neutropenia
2
2023
114
0.400
Why?
Receptors, KIR
2
2008
13
0.390
Why?
Genetic Predisposition to Disease
3
2024
508
0.380
Why?
Bone Diseases
3
2021
97
0.380
Why?
Dose-Response Relationship, Drug
8
2020
1354
0.370
Why?
Pyrimidines
2
2022
192
0.370
Why?
Thrombocytopenia
2
2022
79
0.370
Why?
Azacitidine
1
2010
34
0.370
Why?
Benzamides
1
2010
50
0.360
Why?
Evolution, Molecular
2
2021
97
0.360
Why?
Histone Deacetylase Inhibitors
1
2010
57
0.350
Why?
C-Reactive Protein
6
2022
143
0.350
Why?
Prednisone
2
2021
100
0.340
Why?
Doxorubicin
6
2021
233
0.340
Why?
TOR Serine-Threonine Kinases
2
2020
76
0.330
Why?
Drug Administration Schedule
5
2015
368
0.330
Why?
Chromosome Deletion
5
2023
138
0.330
Why?
Metaphase
4
2016
45
0.320
Why?
Pelvis
2
2021
66
0.320
Why?
Vaccination
4
2022
275
0.320
Why?
Quality of Life
1
2015
836
0.320
Why?
Membrane Glycoproteins
2
2009
244
0.320
Why?
Paraproteinemias
3
2022
71
0.310
Why?
Animals
15
2024
13098
0.310
Why?
Proportional Hazards Models
7
2024
406
0.310
Why?
Placebo Effect
2
2020
16
0.300
Why?
Bone Neoplasms
4
2013
178
0.300
Why?
Adoptive Transfer
1
2007
30
0.300
Why?
Histocompatibility Antigens Class I
1
2007
44
0.290
Why?
Chromatin
3
2023
137
0.290
Why?
CD8-Positive T-Lymphocytes
3
2024
124
0.290
Why?
Cytogenetic Analysis
5
2023
80
0.290
Why?
DNA Methylation
4
2023
544
0.280
Why?
Boron Compounds
2
2024
19
0.280
Why?
Risk Assessment
9
2022
1253
0.280
Why?
Chromans
2
2024
35
0.270
Why?
Vincristine
3
2021
84
0.270
Why?
Mice, SCID
6
2013
173
0.270
Why?
Cell Membrane
1
2007
249
0.270
Why?
Glycine
2
2024
78
0.270
Why?
Angiogenesis Inhibitors
5
2010
182
0.270
Why?
Down-Regulation
1
2007
342
0.270
Why?
In Situ Hybridization, Fluorescence
5
2023
256
0.260
Why?
Neoplasm Staging
6
2024
749
0.260
Why?
Cell Line, Tumor
9
2023
1388
0.260
Why?
Disease Management
2
2018
175
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.250
Why?
Vitamin E
2
2024
76
0.250
Why?
Case-Control Studies
6
2024
1129
0.250
Why?
Transplantation Conditioning
5
2008
82
0.250
Why?
Mice
11
2024
5657
0.250
Why?
Infusions, Intravenous
3
2015
211
0.250
Why?
Bone Resorption
2
2022
297
0.250
Why?
Antibody Formation
1
2005
51
0.240
Why?
Fever
2
2022
110
0.240
Why?
Registries
3
2024
522
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Time Factors
11
2021
2890
0.230
Why?
Flow Cytometry
4
2012
470
0.230
Why?
Monocytes
2
2020
131
0.230
Why?
Gene Expression
2
2018
612
0.220
Why?
High-Throughput Nucleotide Sequencing
3
2022
168
0.220
Why?
Ubiquitin-Protein Ligases
1
2024
93
0.220
Why?
Cell Cycle Proteins
2
2022
167
0.220
Why?
Blotting, Western
3
2015
587
0.220
Why?
Proteasome Endopeptidase Complex
3
2011
116
0.220
Why?
Signal Transduction
6
2021
1608
0.220
Why?
Epstein-Barr Virus Infections
2
2020
29
0.220
Why?
Radiation-Protective Agents
1
2024
72
0.210
Why?
Integrin beta Chains
1
2023
13
0.210
Why?
Prospective Studies
8
2022
2342
0.210
Why?
Integrins
1
2023
30
0.210
Why?
Double-Blind Method
2
2015
679
0.210
Why?
Cross-Sectional Studies
3
2023
1573
0.210
Why?
Young Adult
5
2020
4027
0.210
Why?
Sweating
1
2022
7
0.210
Why?
Hematopoietic Stem Cells
2
2022
182
0.210
Why?
Consensus
2
2020
155
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Proteomics
3
2021
292
0.200
Why?
Kaplan-Meier Estimate
10
2016
463
0.200
Why?
DNA, Intergenic
1
2022
7
0.200
Why?
Tumor Cells, Cultured
4
2013
462
0.200
Why?
Receptors, Antigen, T-Cell
1
2022
49
0.200
Why?
Tumor Suppressor Protein p53
2
2017
213
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
United States
4
2022
4873
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
United States Food and Drug Administration
1
2022
91
0.190
Why?
Influenza, Human
1
2022
83
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Mediastinum
1
2021
20
0.190
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.190
Why?
Receptors, Glucocorticoid
2
2012
32
0.190
Why?
Phosphatidylinositol 3-Kinases
2
2019
139
0.190
Why?
Ubiquitination
1
2021
40
0.190
Why?
Apoptosis
5
2018
1092
0.190
Why?
Axilla
1
2021
90
0.190
Why?
Alleles
3
2021
252
0.190
Why?
Multiple Organ Failure
1
2021
47
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
84
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
103
0.180
Why?
Salvage Therapy
6
2013
136
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
123
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.180
Why?
Rare Diseases
1
2020
43
0.180
Why?
Interferon-gamma
3
2014
176
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Longitudinal Studies
5
2024
693
0.180
Why?
Radiopharmaceuticals
4
2021
204
0.180
Why?
Cytokines
2
2014
607
0.180
Why?
Cell Cycle
1
2021
226
0.180
Why?
Interferon Type I
1
2020
24
0.170
Why?
Myelodysplastic Syndromes
2
2013
79
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Research Design
2
2020
344
0.170
Why?
Multivariate Analysis
8
2021
579
0.170
Why?
Health Status Disparities
1
2022
196
0.170
Why?
Gene Amplification
1
2019
57
0.170
Why?
Genomics
4
2023
284
0.170
Why?
Measles virus
1
2019
8
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Measles
1
2019
7
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
DNA
1
2023
543
0.170
Why?
Data Collection
1
2020
282
0.170
Why?
Oncolytic Virotherapy
1
2019
18
0.160
Why?
Immunohistochemistry
2
2015
972
0.160
Why?
Biopsy
5
2018
591
0.160
Why?
Patient Safety
1
2020
102
0.160
Why?
Sirolimus
1
2019
62
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
Cell Differentiation
6
2022
649
0.160
Why?
Proto-Oncogene Proteins c-akt
1
2019
155
0.160
Why?
Precancerous Conditions
2
2010
83
0.160
Why?
Evidence-Based Medicine
2
2018
247
0.160
Why?
Syndrome
1
2019
237
0.160
Why?
Graft vs Host Disease
4
2007
73
0.160
Why?
MafB Transcription Factor
1
2018
9
0.160
Why?
Spleen
1
2019
170
0.150
Why?
Genomic Instability
2
2016
91
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Immunomodulation
1
2018
37
0.150
Why?
Chemokines
1
2018
75
0.150
Why?
Plasma
1
2018
42
0.150
Why?
Myeloablative Agonists
2
2008
30
0.150
Why?
Hematopoietic Stem Cell Mobilization
2
2008
56
0.150
Why?
Genes, Neoplasm
2
2015
30
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Osteoclasts
3
2022
424
0.150
Why?
Models, Biological
2
2018
719
0.150
Why?
Magnetic Resonance Imaging
5
2013
1525
0.150
Why?
Gene Dosage
2
2015
78
0.150
Why?
Gene Rearrangement
1
2018
73
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Communication
1
2019
246
0.140
Why?
Heterozygote
2
2014
81
0.140
Why?
HLA-A Antigens
2
2007
10
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Protein-Tyrosine Kinases
2
2018
95
0.140
Why?
Drug Therapy, Combination
1
2018
378
0.140
Why?
Retrospective Studies
8
2024
6118
0.140
Why?
Oligonucleotide Array Sequence Analysis
5
2010
409
0.130
Why?
Gene Frequency
2
2013
96
0.130
Why?
Transcriptome
4
2020
312
0.130
Why?
Syndecan-1
4
2021
72
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Lymphocyte Activation
2
2017
171
0.130
Why?
Critical Illness
1
2018
297
0.130
Why?
Confidence Intervals
2
2014
155
0.130
Why?
Adolescent
5
2020
6402
0.130
Why?
Tumor Burden
3
2020
131
0.130
Why?
Erythrocyte Indices
1
2015
7
0.130
Why?
Immunity, Innate
1
2016
104
0.130
Why?
Biomarkers, Pharmacological
2
2012
25
0.130
Why?
DNA Copy Number Variations
3
2022
108
0.130
Why?
Coculture Techniques
2
2013
143
0.120
Why?
Hemoglobins
2
2013
106
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.120
Why?
International Cooperation
1
2014
44
0.120
Why?
Hematologic Diseases
1
2014
21
0.120
Why?
Half-Life
1
2014
85
0.120
Why?
Fatigue
1
2015
118
0.120
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.120
Why?
Iron
1
2015
122
0.120
Why?
Area Under Curve
1
2014
178
0.110
Why?
Antibodies
2
2024
151
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Reference Values
1
2014
302
0.110
Why?
ROC Curve
1
2014
225
0.110
Why?
Emotions
1
2015
165
0.110
Why?
Renal Insufficiency
2
2021
107
0.110
Why?
Severity of Illness Index
2
2014
953
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
74
0.110
Why?
Disease Models, Animal
2
2016
1411
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Inflammation Mediators
1
2014
110
0.110
Why?
Cisplatin
4
2013
275
0.110
Why?
Macaca mulatta
2
2024
92
0.110
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
5
0.110
Why?
Central Nervous System Neoplasms
1
2013
64
0.110
Why?
beta Catenin
1
2013
101
0.100
Why?
Lymph Nodes
3
2021
257
0.100
Why?
Venous Thrombosis
2
2004
88
0.100
Why?
Oligopeptides
1
2013
93
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
64
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Mental Health
1
2015
219
0.100
Why?
Cell Survival
2
2020
590
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Maintenance Chemotherapy
1
2012
49
0.100
Why?
Pain
1
2015
372
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
183
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
197
0.100
Why?
Interleukin-2
1
2012
70
0.100
Why?
Models, Genetic
2
2016
174
0.100
Why?
Cell Movement
1
2013
245
0.100
Why?
Mice, Inbred NOD
1
2012
94
0.100
Why?
Immunoenzyme Techniques
1
2012
141
0.100
Why?
Hemangioma
1
2013
83
0.100
Why?
Soft Tissue Neoplasms
1
2012
56
0.100
Why?
Genotype
1
2013
539
0.100
Why?
Arkansas
5
2021
1987
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
45
0.090
Why?
Chemokine CXCL13
2
2022
5
0.090
Why?
Models, Statistical
2
2014
225
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
53
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
CD40 Ligand
1
2010
14
0.090
Why?
Hypersensitivity, Delayed
1
2010
19
0.090
Why?
Secondary Prevention
1
2010
78
0.090
Why?
Interleukin-4
1
2010
44
0.090
Why?
Up-Regulation
4
2018
446
0.090
Why?
HIV Seropositivity
1
2010
27
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
16
0.090
Why?
Immunity, Cellular
1
2010
69
0.090
Why?
Adjuvants, Immunologic
1
2010
51
0.090
Why?
Cell Line
2
2013
1010
0.090
Why?
Cells, Cultured
3
2013
1587
0.090
Why?
Etoposide
2
2007
71
0.080
Why?
Ovarian Neoplasms
1
2014
450
0.080
Why?
Placenta
1
2011
129
0.080
Why?
Transplantation, Heterologous
1
2009
75
0.080
Why?
Radiography
4
2012
485
0.080
Why?
Histones
2
2021
295
0.080
Why?
Hospitalization
2
2024
663
0.080
Why?
Polymerase Chain Reaction
1
2010
456
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
27
0.080
Why?
Bone and Bones
3
2021
473
0.080
Why?
Transcription Factors
2
2023
565
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Immunoglobulin lambda-Chains
1
2008
14
0.080
Why?
Liver Neoplasms
1
2012
329
0.080
Why?
Haplotypes
1
2008
83
0.080
Why?
Granulocyte Colony-Stimulating Factor
1
2008
60
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Gene Deletion
1
2009
267
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
Ligands
1
2008
203
0.080
Why?
Neoplastic Stem Cells
1
2009
100
0.080
Why?
Osteogenesis
1
2011
353
0.080
Why?
Twins
1
2007
21
0.070
Why?
Busulfan
1
2007
19
0.070
Why?
Diphosphonates
1
2008
90
0.070
Why?
Herpesviridae Infections
2
2019
53
0.070
Why?
Immunophenotyping
1
2007
109
0.070
Why?
Leukocytes, Mononuclear
1
2007
112
0.070
Why?
Caspases
2
2018
104
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Blood Proteins
1
2007
77
0.070
Why?
Creatinine
1
2007
140
0.070
Why?
Skin Neoplasms
1
2012
487
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Immunosuppressive Agents
1
2008
226
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.070
Why?
Cohort Studies
3
2020
1406
0.070
Why?
Plasmacytoma
1
2006
39
0.070
Why?
Chromosome Banding
1
2006
24
0.070
Why?
MicroRNAs
1
2010
347
0.070
Why?
Amiloride
1
2005
8
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Bone Marrow Transplantation
2
2022
112
0.060
Why?
Imaging, Three-Dimensional
2
2017
152
0.060
Why?
Sensitivity and Specificity
1
2007
858
0.060
Why?
Predictive Value of Tests
3
2018
907
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
29
0.060
Why?
Tomography, X-Ray Computed
2
2023
1150
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
4
0.060
Why?
Piperidones
1
2024
5
0.060
Why?
Enoxaparin
1
2004
27
0.060
Why?
Telomere
1
2024
36
0.060
Why?
Retreatment
1
2024
56
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
NF-kappa B
2
2018
315
0.060
Why?
Morpholines
1
2024
66
0.060
Why?
Cost of Illness
1
2024
113
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
Neoplasms
1
2014
1233
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
DNA, Neoplasm
2
2020
145
0.050
Why?
Epidemiologic Methods
3
2008
49
0.050
Why?
Fibroblasts
1
2005
352
0.050
Why?
Gene Silencing
2
2016
114
0.050
Why?
Cluster Analysis
3
2010
233
0.050
Why?
Cell Communication
1
2023
69
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
47
0.050
Why?
Geography
1
2022
61
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Whole-Body Irradiation
1
2022
129
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
19
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Quantitative Trait Loci
1
2022
42
0.050
Why?
Patient Selection
1
2023
254
0.050
Why?
Primary Cell Culture
1
2022
61
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
35
0.050
Why?
Risk
2
2014
314
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Anticoagulants
1
2004
253
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Child, Preschool
2
2020
3863
0.050
Why?
Age of Onset
2
2013
108
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Rabbits
2
2013
376
0.050
Why?
Polymorphism, Genetic
1
2022
181
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Fibrosis
1
2021
178
0.050
Why?
Edema
1
2021
68
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Spatio-Temporal Analysis
1
2020
9
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Base Sequence
1
2022
657
0.040
Why?
Repressor Proteins
1
2022
149
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Genome, Human
1
2021
110
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Genetic Loci
1
2020
44
0.040
Why?
Mice, Transgenic
1
2021
542
0.040
Why?
False Negative Reactions
1
2019
29
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
Incidence
2
2013
989
0.040
Why?
Neoplasm Invasiveness
1
2020
268
0.040
Why?
Europe
1
2019
75
0.040
Why?
Herpesvirus 4, Human
1
2019
39
0.040
Why?
Communicable Disease Control
1
2019
36
0.040
Why?
Computational Biology
1
2020
214
0.040
Why?
RNA, Messenger
2
2016
1099
0.040
Why?
beta 2-Microglobulin
2
2009
38
0.040
Why?
Genome, Viral
1
2019
78
0.040
Why?
Virus Diseases
1
2019
40
0.040
Why?
DNA, Viral
1
2019
133
0.040
Why?
Fibrinogen
1
2018
32
0.040
Why?
Immunoglobulin A
1
2018
45
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
20
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
Platelet Count
2
2008
64
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Pathology, Molecular
1
2018
22
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Immunoglobulin G
1
2018
184
0.040
Why?
Oncogene Proteins, Fusion
1
2018
59
0.040
Why?
Data Interpretation, Statistical
2
2010
159
0.040
Why?
Databases, Factual
2
2013
659
0.040
Why?
Child
2
2020
6826
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
False Positive Reactions
1
2017
60
0.040
Why?
Glomerular Filtration Rate
1
2017
110
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
181
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
19
0.030
Why?
Internationality
1
2017
41
0.030
Why?
Amino Acid Sequence
1
2018
579
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
75
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
Proteolysis
1
2016
93
0.030
Why?
Enzyme Activation
1
2016
272
0.030
Why?
Chromosome Mapping
2
2006
158
0.030
Why?
Prevalence
1
2019
955
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Phosphorylation
1
2016
526
0.030
Why?
Kidney Diseases
1
2017
211
0.030
Why?
Myocardium
1
2017
443
0.030
Why?
Asymptomatic Diseases
1
2014
36
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Capsid
1
2014
3
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
53
0.030
Why?
Cerebrospinal Fluid
1
2013
30
0.030
Why?
Homozygote
1
2013
57
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Nicotinamide Mononucleotide
1
2013
3
0.030
Why?
Diagnosis, Differential
1
2017
1034
0.030
Why?
Acrylamides
1
2013
7
0.030
Why?
Receptors, CXCR4
1
2013
27
0.030
Why?
Niacinamide
1
2013
23
0.030
Why?
Dependovirus
1
2014
103
0.030
Why?
Amides
1
2013
36
0.030
Why?
NAD
1
2013
42
0.030
Why?
Enzyme Induction
1
2013
79
0.030
Why?
Nitriles
1
2013
52
0.030
Why?
Sirtuin 1
1
2013
28
0.030
Why?
Chemokine CXCL12
1
2013
30
0.030
Why?
Gene Knockdown Techniques
1
2013
106
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
RNA, Small Interfering
1
2013
210
0.030
Why?
Infant
1
2020
3564
0.030
Why?
Piperidines
1
2013
96
0.030
Why?
Induction Chemotherapy
1
2012
60
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Acute Disease
1
2013
367
0.020
Why?
Chemokine CXCL10
1
2011
19
0.020
Why?
HIV Infections
1
2016
355
0.020
Why?
Antibodies, Neutralizing
1
2011
62
0.020
Why?
Sex Factors
1
2013
691
0.020
Why?
Pharmacogenetics
1
2011
50
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
24
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
46
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
46
0.020
Why?
Enzyme Inhibitors
1
2013
378
0.020
Why?
Microarray Analysis
1
2010
73
0.020
Why?
International Classification of Diseases
1
2010
63
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
RNA-Binding Proteins
1
2011
120
0.020
Why?
Oligonucleotides
1
2010
81
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
63
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Neoplasm Metastasis
1
2009
235
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Polyethylene Glycols
1
2008
85
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
550
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
212
0.020
Why?
Age Distribution
1
2007
169
0.020
Why?
Recombinant Proteins
1
2008
482
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
81
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
179
0.020
Why?
Brain
1
2013
1310
0.020
Why?
Survivors
1
2006
120
0.020
Why?
Pregnancy
1
2011
2466
0.010
Why?
Probability
1
2003
163
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Administration, Oral
1
2003
430
0.010
Why?
Tissue Donors
1
2003
111
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description